Skip to content
Use caution Drug recall · FDA · Published November 3, 2020

Teligent Recalls Triamcinolone Lotion Due to Subpotency

Teligent Pharma recalls one lot of Triamcinolone Acetonide Lotion USP, 0.025% because it does not meet assay results for potency.

🇺🇸 FDA recall #D-0110-2021DrugTeligent Pharma ›
Take action

Contact the company

Recalling firmTeligent Pharma, Inc.105 Lincoln Avenue · Buena, NJ 08310
✎ GovInfoNow plain-language explainer

Teligent Pharma, Inc. is recalling one specific lot of Triamcinolone Acetonide Lotion USP, 0.025% because the product is subpotent and does not meet its labeled assay results. This means the medication may not work as intended to treat skin conditions. The recall affects 4,008 units distributed nationwide in the USA. Read more at govinfonow.com/recall/36690-teligent-recalls-triamcinolone-lotion-due-to-subpotency.

Source Summary by GovInfoNow · govinfonow.com/recall/36690-teligent-recalls-triamcinolone-lotion-due-to-subpotency · Updated October 11, 2026 · FDA enforcement record: FDA #D-0110-2021

Cite this page

“Teligent Recalls Triamcinolone Lotion Due to Subpotency.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/36690-teligent-recalls-triamcinolone-lotion-due-to-subpotency. Based on FDA recall #D-0110-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0110-2021%22&limit=1).

The FDA announced on November 3, 2020, that Teligent Pharma, Inc. voluntarily recalled one lot of Triamcinolone Acetonide Lotion USP due to subpotency issues. The recall affects 4,008 units distributed nationwide.

How to tell if you have it

  • Brand: Teligent Pharma
  • Product: Triamcinolone Acetonide Lotion USP, 0.025%, 60 mL (60 grams) bottle, Rx Only
  • NDC: 52565-010-59
  • Lot #: 14481
  • Expiration Date: 10/31/2021

The hazard

One lot of Triamcinolone Acetonide Lotion, 0.025% 60 mL does not meet assay results, resulting in a subpotent drug classification.

Context

GovInfoNow's records show Teligent Pharma, Inc. has had 18 other recalls since May 20, 2019. Recent brand recalls include a March 15, 2022 recall of Hydrocortisone Lotion for cGMP deviations and a February 7, 2022 recall of Erythromycin Gel due to impurities risk. Other recent recalls of similar products include CoValence Laboratories Skin Rehab Gel Recall (March 18, 2026), CoValence Laboratories Remedy Gel Hydrocortisone 1% Recall (March 18, 2026), and Specialty Process Labs Thyroid Product Recall (January 16, 2026).

How to tell if you have this one

Check your bottle for NDC 52565-010-59 and Lot #14481. The product is a 60 mL (60 grams) Rx-only bottle manufactured by Teligent Pharma, Inc. in Buena, New Jersey, with an expiration date of 10/31/2021.

  • Brand
    Teligent Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your product matches NDC 52565-010-59 and Lot #14481.

  2. Contact Your Pharmacist

    Speak with your healthcare provider or pharmacist about replacing the subpotent medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.1 years after the firm started it.

1. Firm started the recall: Nov 3, 202012. FDA classified it Class III: Nov 25, 202023. Published in FDA’s Enforcement Report: Dec 2, 202034. FDA terminated the recall: Dec 21, 2023420202023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0110-2021 (November 3, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0110-2021 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA